NCT01473082View on ClinicalTrials.gov

Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation

PHASE4CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Hip FracturesClosed Fracture of Hip
Interventions
DEVICE

PFNA Augmentation (Synthes)

Proximal Femoral Nail Antirotation (PFNA) Augmentation (with Traumacem V+)

DEVICE

PFNA (Synthes)

Proximal Femoral Nail Antirotation (PFNA)

Trial Locations (9)

3000

KUL Univ. Ziekenhuizen Leuven, Leuven

3103

Sykehuset i Vestfold HF Tønsberg, Tønsberg

6000

Cantonal Hospital Lucerne, Lucerne

6020

Medical University of Innsbruck, Innsbruck

8037

City Hospital Waid, Zurich

72076

BGU Tübingen, Tübingen

89075

University of Ulm, Ulm

91120

Hadassah Medical Organization, Jerusalem

99425

Sophien und Hufeland Klinikum GmbH, Weimar

All Listed Sponsors
lead

AO Clinical Investigation and Publishing Documentation

OTHER

NCT01473082 - Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation | Biotech Hunter | Biotech Hunter